期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
Therapeutic response and safety of different treatments for cutaneous leishmaniasis in patients: A retrospective cross-sectional study
1
作者 Nicolás Rozo Montoya Juliana Quintero Pulgarín Liliana López Carvajal 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2023年第7期305-312,共8页
Objective:To analyze the therapeutic response and safety of different treatments for cutaneous leishmaniasis,received by patients in the Program for the Study and Control of Tropical Diseases-PECET-Medellín-Colom... Objective:To analyze the therapeutic response and safety of different treatments for cutaneous leishmaniasis,received by patients in the Program for the Study and Control of Tropical Diseases-PECET-Medellín-Colombia.Methods:This is a retrospective cross-sectional study of patients attended at PECET Research Center during 2016-2021.Relevant information regarding sociodemographic characteristics,history of leishmaniasis,characterization of current infection,treatment received,follow-up of therapeutic response and safety was collected from the medical records.Data were analyzed with Pearson's Chi-square association tests and Mann-Whitney U test using statistical software.Results:A total of 486 clinical records of patients were analyzed,and 356 received treatment.Eight different therapeutic alternatives(systemic,local and in combination)were analyzed.The therapeutic response of the different alternatives used(except thermotherapy)was higher than 50%.Most frequent adverse events were myalgias,arthralgias and headache,and vesicles for systemic and local treatment,respectively.Conclusions:Safety profile and performance of local therapeutic alternatives and combined schemes for the treatment of uncomplicated cutaneous leishmaniasis are an interesting option for the management of the disease. 展开更多
关键词 Cutaneous leishmaniasis Systemic treatment Local treatment Combined treatment Tropical neglected disease SAFETY therapeutic response
下载PDF
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B 被引量:1
2
作者 Siyu Zhang Xiaoxiao Zhang +7 位作者 Huiming Jin Yao Dou Lu Li Xiwei Yuan Chen Dong Mengmeng Hou Yue-min Nan Jia Shang 《Journal of Clinical and Translational Hepatology》 SCIE 2023年第1期67-75,共9页
Background and Aims:The impact of nonalcoholic fatty liver disease(NAFLD)on the treatment outcome of chronic hepatitis B(CHB)is undefined and deserves an in-depth investigation.Methods:Histologically-proven CHB receiv... Background and Aims:The impact of nonalcoholic fatty liver disease(NAFLD)on the treatment outcome of chronic hepatitis B(CHB)is undefined and deserves an in-depth investigation.Methods:Histologically-proven CHB receiving first-line antiviral regimens as initial therapy was enrolled and grouped by the concurrence of NAFLD,and followed up at six monthly intervals.Therapeutic response related data were recorded and compared at multiple time points.Kaplan-Meier and Cox regression analyses were utilized to estimate the impact of NAFLD on complete virological response(CVR).Results:We enrolled 267 patients(CHB:164;CHB with NAFLD:103)with comparable follow-up durations.They were also comparable in baseline HBV DNA levels and HBeAg positivity.Patients with concomitant NAFLD showed less significant decline in HBV DNA,qHBsAg,pgRNA,and liver enzyme levels over time;moreover,their cumulative incidences of CVR were significantly lower and that of low-level viremia(LLV)were significantly higher at 6,12,18,24 months.First CVR of CHB was delayed with the presence NAFLD(11.0 vs.7.0 months,p<0.001)and further prolonged with higher grade of liver steatosis(Grade 2–3 vs.1:13.0 vs.9.0 months).On multivariate analysis,HBeAg positivity(HR:0.650,p=0.036),grade of steatosis(G2[HR:0.447,p=0.004];G3[HR:0.085,p=0.002])and HBV DNA(log10 IU/mL)(HR:0.687,p<0.001)were significantly associated with delayed CVR,whereas grade of necroinflammation(HR:1.758,p<0.001)accelerated the CVR.Conclusions:In CHB patients receiving initial antiviral therapy,NAFLD was associated with higher levels of HBV DNA,pgRNA,and liver enzymes,and higher incidence of LLV and delayed CVR. 展开更多
关键词 Chronic hepatitis B Nonalcoholic fatty liver disease therapeutic response HBV pregenomic RNA Low-level viremia
原文传递
Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response
3
作者 Yuanliang Yan Jinwu Peng +7 位作者 Qiuju Liang Xinxin Ren Yuan Cai Bi Peng Xi Chen Xiang Wang Qiaoli Yi Zhijie Xu 《Genes & Diseases》 SCIE CSCD 2023年第1期135-150,共16页
Several types of modifications have been proven to participate in the metabolism and processing of different RNA types,including non-coding RNAs(ncRNAs).N-6-methyladenosine(m6A)is a dynamic and reversible RNA modifica... Several types of modifications have been proven to participate in the metabolism and processing of different RNA types,including non-coding RNAs(ncRNAs).N-6-methyladenosine(m6A)is a dynamic and reversible RNA modification that is closely involved in the ncRNA homeostasis,and serves as a crucial regulator for multiple cancer-associated signaling pathways.The ncRNAs usually regulate the epigenetic modification,mRNA transcription and other biological processes,displaying enormous roles in human cancers.In this review,we summarized the significant implications of m6A-ncRNA interaction in various types of cancers.In particular,the interplay between m6A and ncRNAs in cancer pathogenesis and therapeutic resistance are being widely recognized.We also discussed the relevance of m6A-ncRNA interaction in immune regulation,followed by the interference on cancer immunotherapeutic procedures.In addition,we briefly highlighted the computation tools that could identify the accurate features of m6A methylome among ncRNAs.In summary,this review would pave the way for a better understanding of the biological functions of m6A-ncRNA crosstalk in cancer research and treatment. 展开更多
关键词 CANCER Immune regulation N-6-Methyladenosine Non-coding RNAs therapeutic response
原文传递
Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responses 被引量:1
4
作者 Cheng Zhang Jiao‐jiao Yu +4 位作者 Chen Yang Shuang Shang Xiao‐xi Lv Bing Cui Fang Hua 《Cancer Innovation》 2022年第1期92-113,共22页
Ferroptosis is a newly discovered form of cell death that is characterized by the accumulation of iron‐dependent lipid peroxidation.Research on ferroptosis has seen exponential growth over the past few years.Tumor ce... Ferroptosis is a newly discovered form of cell death that is characterized by the accumulation of iron‐dependent lipid peroxidation.Research on ferroptosis has seen exponential growth over the past few years.Tumor cells are strongly dependent on iron for their growth,which makes them develop mechanisms to increase iron uptake and inhibit iron output,thereby completing iron accumulation.Ferroptosis can be induced or inhibited by various stresses through multiple mechanisms,making it stands at the crossroads of stresses related cancer cell fate determination.In this review,we give a brief summary of ferroptosis hallmarks and provide a systematic analysis of the current molecular mechanisms and regulatory networks of diverse stress conditions on ferroptosis.We also discuss the relationships between ferroptosis and cancer therapy responses to further understand potential targets and therapeutic strategies for cancer treatment. 展开更多
关键词 tumor therapeutic response ferroptosis STRESS CROSSTALK
下载PDF
Role of radiomics in the diagnosis and treatment of gastrointestinal cancer
5
作者 Qi Mao Mao-Ting Zhou +3 位作者 Zhang-Ping Zhao Ning Liu Lin Yang Xiao-Ming Zhang 《World Journal of Gastroenterology》 SCIE CAS 2022年第42期6002-6016,共15页
Gastrointestinal cancer(GIC)has high morbidity and mortality as one of the main causes of cancer death.Preoperative risk stratification is critical to guide patient management,but traditional imaging studies have diff... Gastrointestinal cancer(GIC)has high morbidity and mortality as one of the main causes of cancer death.Preoperative risk stratification is critical to guide patient management,but traditional imaging studies have difficulty predicting its biological behavior.The emerging field of radiomics allows the conversion of potential pathophysiological information in existing medical images that cannot be visually recognized into high-dimensional quantitative image features.Tumor lesion characterization,therapeutic response evaluation,and survival prediction can be achieved by analyzing the relationships between these features and clinical and genetic data.In recent years,the clinical application of radiomics to GIC has increased dramatically.In this editorial,we describe the latest progress in the application of radiomics to GIC and discuss the value of its potential clinical applications,as well as its limitations and future directions. 展开更多
关键词 Gastrointestinal cancer DIAGNOSIS TREATMENT Radiomics therapeutic response Hepatocellular carcinoma
下载PDF
Body mass index is a promising predictor of response to oral rehydration saline in children with vasovagal syncope 被引量:2
6
作者 Chun-Yan Tao Selena Chen +3 位作者 Xue-Ying Li Chao-Shu Tang Jun-Bao Du Hong-Fang Jin 《Chinese Medical Journal》 SCIE CAS CSCD 2021年第4期463-468,共6页
Background:Vasovagal syncope(VVS)greatly impairs quality of life.The therapeutic efficacy of oral rehydration saline(ORS)for unselected VVS patients is not satisfactory due to the diverse mechanisms of the disease.Bod... Background:Vasovagal syncope(VVS)greatly impairs quality of life.The therapeutic efficacy of oral rehydration saline(ORS)for unselected VVS patients is not satisfactory due to the diverse mechanisms of the disease.Body mass index(BMI)was demonstrated to reflect blood volume to a certain extent.Therefore,the present study explored the capability of BMI to predict the therapeutic response of children with VVS to ORS treatment.Methods:Seventy-four children with VVS who visited the Syncope Unit of Pediatrics at Peking University First Hospital from November 2010 to June 2019 receiving ORS treatment were enrolled for this retrospective case-control study.A comparison of demographic,clinical,and hemodynamic characteristics was performed between responders and non-responders.The correlation between baseline BMI and response time was analyzed.To determine the value of baseline BMI in predicting the therapeutic efficacy of ORS in children with VVS,a receiver operating characteristic curve analysis was performed.Results:Fifty-two children were identified as responders,and the remaining 22 children were identified as non-responders.The baseline BMI of the responders was much lower than that of the non-responders(16.4[15.5,17.8]kg/m2vs.20.7±3.6 kg/m2,P<0.001),and baseline BMI was positively correlated with response time in the head-up tilt test after adjusting for sex(r=0.256,95%confidence interval[CI]:0.067-0.439,P=0.029).The area under the receiver operating characteristic curve of baseline BMI was 0.818(95%CI:0.704-0.932,P<0.001),and an optimal cut-off value of 18.9 kg/m2 yielded a sensitivity of 83%and a specificity of 73%to predict the efficacy of ORS in VVS.Conclusion:Prior to treatment,baseline BMI is a promising predictor of response to ORS in children with VVS. 展开更多
关键词 Vasovagal syncope Oral rehydration saline Body mass index therapeutic response
原文传递
淋巴细胞密度及分布与直肠癌新辅助治疗反应的关系 被引量:1
7
作者 Sicong Lai Xiaoying Lou +5 位作者 Xinjuan Fan Weipeng Sun Yanhong Deng Jianping Wang Yan Huang Ruoxu Dou 《Gastroenterology Report》 SCIE EI 2020年第6期445-452,I0002,共9页
背景:研究认为,淋巴细胞密度与直肠癌预后相关;但新辅助治疗前淋巴细胞分布模式对预后的影响尚不清楚。本研究旨在评估淋巴细胞的分布及密度与直肠癌新辅助治疗反应的关系。方法:对前瞻性队列中接受新辅助治疗的134例直肠癌患者进行回... 背景:研究认为,淋巴细胞密度与直肠癌预后相关;但新辅助治疗前淋巴细胞分布模式对预后的影响尚不清楚。本研究旨在评估淋巴细胞的分布及密度与直肠癌新辅助治疗反应的关系。方法:对前瞻性队列中接受新辅助治疗的134例直肠癌患者进行回顾性分析。对新辅助治疗前活检标本进行免疫组化染色(CD4和CD8)。评估瘤内腺体周围淋巴细胞(IPL)和肿瘤浸润淋巴细胞(TIL)的密度。采用logistic回归模型(包括临床病理特征、分子特征及治疗方案)评估不同淋巴细胞的密度与肿瘤退缩分级(TRG)的关系。结果:CD8^(+)TIL密度高的患者接受新辅助治疗后获得了更佳的TRG(OR=0.23,95%CI:0.07-0.76,P<0.001)。而CD8^(+)IPL(P=0.033)、CD4^(+)IPL(P=0.156)和CD4^(+)TIL(P=0.170)则与TRG无明显相关性。敏感性分析未发现CD8^(+)TIL与新辅助放疗(P_(相互作用)=0.831)或化疗(P_(交互作用)=0.879)对TRG的影响存在交互作用。结论:本研究结果显示,CD8^(+)TIL而不是CD8^(+)IPL,可独立影响直肠癌新辅助治疗反应,这种影响不受放疗或化疗方案的干扰。 展开更多
关键词 neoadjuvant therapy tumor-infiltrating lymphocytes therapeutic response locally advanced rectal cancer
下载PDF
Magnetic-Optical Imaging for Monitoring Chemodynamic Therapy
8
作者 WANG Youjuan YE Zhifei +1 位作者 SONG Guosheng LIU Zhuang 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2022年第2期481-492,共12页
Chemodynamic therapy kills cancer cells with reactive oxygen species generated by endogenous triggers in the tumor microenvironment.Although chemodynamic therapy is blossoming in recent years,their therapy process sti... Chemodynamic therapy kills cancer cells with reactive oxygen species generated by endogenous triggers in the tumor microenvironment.Although chemodynamic therapy is blossoming in recent years,their therapy process still faces a series of hampers.The unknown catalytic activity of chemodynamic therapy reagents may lead to unpredictable therapy effects,so it is necessary to reveal the therapeutic mechanism of chemodynamic therapy and develop self-monitoring probes.In this mini-review,we summarize and illustrate the most recent progress of chemodynamic therapy,focusing on the applications of magnetic imaging and optical imaging probe for monitoring cancer chemodynamic therapy.Furthermore,we also discuss the potential challenges and the further directions of this field. 展开更多
关键词 Chemodynamic therapy Magnetic imaging Optical imaging NANOPROBE Monitoring therapeutic response
原文传递
多等位基因预测英夫利昔单抗治疗克罗恩病的原发性无应答
9
作者 Cai-Bin Zhang Jian Tang +3 位作者 Xue-Ding Wang Kun-Sheng Lyu Min Huang Xiang Gao 《Gastroenterology Report》 SCIE EI 2021年第5期427-434,I0002,共9页
背景:英夫利昔单抗(IFX)是治疗克罗恩病的一线药物,价格昂贵。IFX的疗效具有显著的个体化差异,目前已知的单核苷酸多态性(SNP)预测IFX疗效效果欠佳。本研究旨在寻找与IFX治疗失败相关的新的遗传学标志物,并建立一个IFX原发性无应答的预... 背景:英夫利昔单抗(IFX)是治疗克罗恩病的一线药物,价格昂贵。IFX的疗效具有显著的个体化差异,目前已知的单核苷酸多态性(SNP)预测IFX疗效效果欠佳。本研究旨在寻找与IFX治疗失败相关的新的遗传学标志物,并建立一个IFX原发性无应答的预测模型。方法:回顾性纳入接受IFX治疗的中国克罗恩病患者,采用克罗恩病简易内镜评分判定原发性无应答和继发性失应答。本研究总共检测了44个基因的125个SNP,建立基于SNP的多因素逻辑回归模型来预测IFX治疗无应答,并通过受试者工作特征曲线下面积(AUROC)来评价此模型的预测价值。结果:206例患者中,有42例(20.4%)患者对IFX原发性无应答;在159例接受IFX持续性治疗的患者中,有15例(9.4%)患者出现继发性失应答。在所检测的125个SNP中,有9个SNP与IFX原发性无应答相关(均P<0.05)。建立包括第2周超敏C反应蛋白(hs-CRP)、rs61886887、rs61740234、rs357291、rs2269330和rs111504845等指标的IFX原发性无应答预测模型,该模型在训练集中和测试集中的AUROC分别为0.818(P<0.001)和0.888(P<0.001)。此外,第14周hs-CRP≥2.25mg/L的患者继发性失应答的发生风险显著增高(AUROC=0.815,P<0.001)。而与IFX原发性无应答显著相关的9个SNP均与继发性失应答无关,说明IFX原发性无应答与继发性失应答之间的发生机制可能是不同的。结论:在中国克罗恩病患者中,单核苷酸多态性与IFX疗效显著相关。 展开更多
关键词 INFLIXIMAB Crohn’s disease single nucleotide polymorphism therapeutic response
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部